Exalenz Bioscience Ltd Share Price
Equities
EXEN
IL0011048688
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- ILa | -.--% | +1.39% | +107.88% |
Sales 2018 | 13.14M 3.58M 1.31B 299M | Sales 2019 | 14.04M 3.83M 1.4B 319M | Capitalization | 77.67M 21.17M 7.77B 1.77B |
---|---|---|---|---|---|
Net income 2018 | -5M -1.36M -500M -114M | Net income 2019 | -1M -273K -100M -22.73M | EV / Sales 2018 | 15.2 x |
Net Debt 2018 | 2.93M 798K 293M 66.54M | Net Debt 2019 | 3.09M 843K 309M 70.31M | EV / Sales 2019 | 5.75 x |
P/E ratio 2018 |
-34.6
x | P/E ratio 2019 |
-40
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 24.36% |
Managers | Title | Age | Since |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01/10/01 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29/19/29 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01/07/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04/16/04 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01/06/01 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16/15/16 |
1st Jan change | Capi. | |
---|---|---|
+107.88% | 45.97M | |
-4.98% | 181B | |
+2.84% | 112B | |
-2.68% | 67.92B | |
+4.53% | 50.1B | |
+8.00% | 44.27B | |
+9.39% | 40.41B | |
+25.30% | 31.95B | |
-0.17% | 25.82B | |
+17.27% | 25.29B |
- Stock Market
- Equities
- EXEN Stock